Nanosphere Rallying After Jefferies Upgrade
Nanosphere (NASDAQ: NSPH) is trading higher on the session after a positive research report by Jefferies. In the report, Jefferies upgrades Nanosphere from Hold to Buy and raises the price target from $2 to $5.
Jefferies states, "We are upgrading NSPH to Buy (from Hold) on expectations for its recently FDA approved gram-positive blood stream infection test to drive a significant acceleration in new system placements & revenue. We are raising our 2012 & 2013 revenue forecasts to $9.5M (from $9M) and $28M (from $20M), respectively. Our PT moves to $5 (from $2) on higher cash flow forecasts."
Nanosphere is currently trading at $3.22, a gain of $0.70 or 27.78%.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.